Global Transcatheter Heart Valve Replacement and Repair Market Growth (Status and Outlook) 2023-2029

Global Transcatheter Heart Valve Replacement and Repair Market Growth (Status and Outlook) 2023-2029

The Transcatheter Heart Valve Replacement and Repair industry can be broken down into several segments, TAVR, TPVR and TMVR.
Valvular heart diseases are associated with the person’s advancing age, caused by the congenital defects or inefficiency of valves to function. Valve dysfunction results in restricting physical activities that leads to decline in quality of life and even death. Hence, due to these reasons many years have been spent on developing heart valve devices in order to repair and replace the damaged heart valves. Over the past few years innovation and recent technological advancements have resulted in manufacturing of transcatheter heart valve that are less risky and need minimally invasive surgical procedure. Increase in number of people with valvular heart disease and rise in demand for minimally invasive surgical procedure will augment the growth of transcatheter heart valve replacement industry in the near future.
LPI (LP Information)' newest research report, the “Transcatheter Heart Valve Replacement and Repair Industry Forecast” looks at past sales and reviews total world Transcatheter Heart Valve Replacement and Repair sales in 2022, providing a comprehensive analysis by region and market sector of projected Transcatheter Heart Valve Replacement and Repair sales for 2023 through 2029. With Transcatheter Heart Valve Replacement and Repair sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcatheter Heart Valve Replacement and Repair industry.
This Insight Report provides a comprehensive analysis of the global Transcatheter Heart Valve Replacement and Repair landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transcatheter Heart Valve Replacement and Repair portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcatheter Heart Valve Replacement and Repair market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcatheter Heart Valve Replacement and Repair and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcatheter Heart Valve Replacement and Repair.
The global Transcatheter Heart Valve Replacement and Repair market size is projected to grow from US$ 5834.1 million in 2022 to US$ 16260 million in 2029; it is expected to grow at a CAGR of 15.8% from 2023 to 2029.
The classification of Transcatheter Heart Valve Replacement and Repair includes TAVR, TPVR and TMVR. The proportion of TAVR in 2019 is about 80%.
North America and Europe are the largest consumption place, with a revenue market share nearly 95% in 2019. APAC has the highest growth in the market. The market is expected to grow at a faster pace due to significant developments and sales in countries such as India, Malaysia, South Korea and China.
Market competition is not intense. Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
This report presents a comprehensive overview, market shares, and growth opportunities of Transcatheter Heart Valve Replacement and Repair market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
TAVR
TPVR
TMVR
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica

Please note: The report will take approximately 2 business days to prepare and deliver.